Business Description
Telesis Bio Inc
NAICS : 423450
SIC : 5047
Description
Telesis Bio Inc is a synthetic biology company focused on enabling researchers to rapidly, accurately, and reproducibly build or write high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology-enabled markets. It manufactures and sells laboratory equipment, specifically synthetic biology instruments, reagents, and associated products and related services. Its products comprise of BioXp system, BioXp kits, Benchtop reagents, Coronavirus tools, and BioXp biofoundry services.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.03 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.46 | |||||
| Debt-to-EBITDA | -0.48 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -1.67 | |||||
| Beneish M-Score | -2.24 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 81.59 | |||||
| 9-Day RSI | 74.98 | |||||
| 14-Day RSI | 70.82 | |||||
| 6-1 Month Momentum % | 1.75 | |||||
| 12-1 Month Momentum % | -62.34 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.08 | |||||
| Quick Ratio | 3.92 | |||||
| Cash Ratio | 3.23 | |||||
| Days Inventory | 68.28 | |||||
| Days Sales Outstanding | 65.52 | |||||
| Days Payable | 80.98 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 56.84 | |||||
| Operating Margin % | -169.44 | |||||
| Net Margin % | -176.68 | |||||
| ROE % | -72.68 | |||||
| ROA % | -49.04 | |||||
| ROIC % | -150.67 | |||||
| ROC (Joel Greenblatt) % | -601.17 | |||||
| ROCE % | -55.71 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.09 | |||||
| PB Ratio | 1.83 | |||||
| Price-to-Tangible-Book | 2.85 | |||||
| EV-to-EBIT | -1.06 | |||||
| EV-to-EBITDA | -1.13 | |||||
| EV-to-Revenue | 1.83 | |||||
| EV-to-FCF | -1.16 | |||||
| Price-to-Net-Current-Asset-Value | 4.24 | |||||
| Price-to-Net-Cash | 9.6 | |||||
| Earnings Yield (Greenblatt) % | -94.34 |
How Telesis Bio Inc (TBIO) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TBIO
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Telesis Bio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 27.435 | ||
| EPS (TTM) ($) | -1.65 | ||
| Beta | 0 | ||
| Volatility % | 97.45 | ||
| 14-Day RSI | 70.82 | ||
| 14-Day ATR ($) | 0.345715 | ||
| 20-Day SMA ($) | 2.0938 | ||
| 12-1 Month Momentum % | -62.34 | ||
| 52-Week Range ($) | 1.0801 - 6.5 | ||
| Shares Outstanding (Mil) | 29.65 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Telesis Bio Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Telesis Bio Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Telesis Bio Inc Frequently Asked Questions
What is Telesis Bio Inc(TBIO)'s stock price today?
The current price of TBIO is $2.88. The 52 week high of TBIO is $6.50 and 52 week low is $1.08.
When is next earnings date of Telesis Bio Inc(TBIO)?
The next earnings date of Telesis Bio Inc(TBIO) is 2023-05-10 Est..
Does Telesis Bio Inc(TBIO) pay dividends? If so, how much?
Telesis Bio Inc(TBIO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
